Global: Cheap antibiotic halves risk of death in first 18 months of ART

Use of cotrimoxazole, a cheap and widely available antibiotic, cut the death rate by half in the first 72 weeks on antiretroviral therapy in over 3,000 HIV-infected, symptomatic and severely immunosuppressed patients in Uganda and Zimbabwe, Sarah Walker and colleagues reported in an analysis of the DART trial published on March 29 in the online edition of The Lancet.